Drug:
Reaction: ALOPECIA
20260101 - 20261231
No. 301 - 400
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 301 | 26496921 |
US |
55 | 1 |
Necrosis of artery, Alopecia, Acne, Weight increased, |
||||
UPADACITINIB, UPADACITINIB, UPADACITINIB, LORATADINE, LORATADINE TABLET, ERGOCALCIFEROL, LISINOPRIL, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, CLONIDINE, MAGNESIUM, |
||||
| 302 | 26497311 |
US |
2 | |
Alopecia, |
||||
RIVAROXABAN, LORLATINIB, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, |
||||
| 303 | 26497366 |
US |
74 | 2 |
Alopecia, |
||||
TIRZEPATIDE, |
||||
| 304 | 26491949 |
US |
2 | |
Lymphoma, Neoplasm, Lymphoedema, Nausea, Alopecia, Rash, Depression, Dyspnoea, Chest discomfort, Cough, |
||||
OSIMERTINIB, |
||||
| 305 | 26491967 |
US |
1 | |
Alopecia, |
||||
TIRZEPATIDE, |
||||
| 306 | 26492298 |
US |
65 | 1 |
Onychomadesis, Alopecia, |
||||
ROSUVASTATIN, CARVEDILOL, SERTRALINE, |
||||
| 307 | 26492744 |
EU |
2 | |
Hyperkalaemia, Hypercalcaemia, Vitamin D deficiency, Alopecia, Arthralgia, |
||||
LETROZOLE, LETROZOLE TABLETS, RIBOCICLIB, RIBOCICLIB, CALCIUM, |
||||
| 308 | 26492758 |
CA |
73 | |
Chest discomfort, Erythema, Feeling hot, Skin burning sensation, Dyspnoea, Pruritus, Hyperhidrosis, Alopecia, Drug specific antibody present, Drug level below therapeutic, Off label use, Overdose, Intentional product use issue, |
||||
INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, PANTOPRAZOLE, PREDNISONE, |
||||
| 309 | 26492889 |
US |
||
Alopecia, |
||||
TIRZEPATIDE, |
||||
| 310 | 26493075 |
EU |
1 | |
Erectile dysfunction, Fatigue, Dizziness, Confusional state, Hot flush, Sensation of foreign body, Emotional distress, Alopecia, Limb discomfort, |
||||
ENZALUTAMIDE, LEUPROLIDE ACETATE, |
||||
| 311 | 26493212 |
CA |
44 | |
Abdominal discomfort, Abdominal pain, Abdominal pain upper, Alopecia, Anti-cyclic citrullinated peptide antibody positive, Arthralgia, Arthropathy, Asthenia, Asthma, Blister, Blood cholesterol increased, Bursitis, C-reactive protein abnormal, Condition aggravated, Confusional state, Death neonatal, Diarrhoea, Discomfort, Dizziness, Adverse event, Adverse drug reaction, Contraindicated product administered, Product use issue, Exposure during pregnancy, Intentional product use issue, Live birth, Maternal exposure during pregnancy, Maternal exposure timing unspecified, Off label use, Pregnancy, Prescribed overdose, Intentional product use issue, Intentional product use issue, Intentional product use issue, |
||||
RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, USTEKINUMAB, USTEKINUMAB, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, APREPITANT, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, CALCIUM, CALCIUM CARBONATE, ANTACID, CELECOXIB, CELECOXIB, CELECOXIB, CERTOLIZUMAB PEGOL, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DOXYCYCLINE, DOXYCYCLINE HYCLATE, DOXYCYCLINE, DOXYCYCLINE HYCLATE, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, GOLIMUMAB, GOLIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE BUTYRATE, HYDROCORTISONE BUTYRATE, HYDROCORTISONE SODIUM SUCCINATE, HYDROCORTISONE SODIUM SUCCINATE, HYDROCORTISONE SODIUM SUCCINATE, HYDROCORTISONE SODIUM SUCCINATE, HYDROCORTISONE SODIUM SUCCINATE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, NAPROXEN SODIUM, NAPROXEN SODIUM 220MG, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, NAPROXEN SODIUM, NAPROXEN SODIUM 220MG, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, NAPROXEN SODIUM, NAPROXEN SODIUM 220MG, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, NAPROXEN SODIUM, NAPROXEN SODIUM 220MG, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, NEOMYCIN OINTMENT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, APREMILAST, OXYCODONE, OXYCODONE HYDROCHLORIDE, OXYCODONE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREGABALIN, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, INFLIXIMAB, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, APREMILAST, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PREGABALIN, |
||||
| 312 | 26493370 |
US |
2 | |
Alopecia, |
||||
MINOXIDIL, |
||||
| 313 | 26493418 |
EU |
||
Death, Concomitant disease aggravated, Disease recurrence, Nail disorder, Haematotoxicity, Disease progression, Diarrhoea, Fatigue, Alopecia, Neuropathy peripheral, Breast cancer metastatic, Asthenia, |
||||
PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, DOCETAXEL, DOCETAXEL ANHYDROUS, DOCETAXEL, DOCETAXEL ANHYDROUS, DOCETAXEL, DOCETAXEL ANHYDROUS, FULVESTRANT, FULVESTRANT, GOSERELIN, GOSERELIN, LETROZOLE, LETROZOLE TABLETS, LETROZOLE, LETROZOLE TABLETS, PERTUZUMAB, TRASTUZUMAB, TRASTUZUMAB, |
||||
| 314 | 26494122 |
54 | 2 | |
Pulmonary toxicity, Transaminases increased, Alopecia, |
||||
| 315 | 26494492 |
US |
63 | 2 |
Haematochezia, Alopecia, |
||||
TIRZEPATIDE, |
||||
| 316 | 26495247 |
US |
||
Hair texture abnormal, Alopecia, |
||||
KETOCONAZOLE, |
||||
| 317 | 26495267 |
EU |
63 | 2 |
Spinal fracture, Alopecia, Dry skin, Weight decreased, Pruritus, Contusion, Bone pain, Dizziness, Headache, Tachycardia, Vertigo, |
||||
ABALOPARATIDE, DENOSUMAB, DENOSUMAB, |
||||
| 318 | 26495564 |
US |
2 | |
Alopecia, |
||||
DENOSUMAB, ABATACEPT, |
||||
| 319 | 26495609 |
US |
69 | 2 |
Constipation, Secretion discharge, Dysphonia, Anxiety, Breast mass, Lymphadenopathy, Swelling, Fatigue, Exophthalmos, Ear pruritus, Ear discomfort, Sensation of foreign body, Alopecia, Impaired gastric emptying, Swollen tongue, |
||||
DULAGLUTIDE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, POLYETHYLENE GLYCOL 3350, |
||||
| 320 | 26495614 |
CA |
44 | 2 |
Abdominal pain, Abdominal pain upper, Alopecia, Anti-cyclic citrullinated peptide antibody positive, Anxiety, Arthralgia, Arthropathy, Asthenia, Asthma, Autoimmune disorder, Blister, Blood cholesterol increased, Bursitis, C-reactive protein abnormal, Chest pain, Condition aggravated, Confusional state, Contraindicated product administered, Contusion, Decreased appetite, Deep vein thrombosis postoperative, Diarrhoea, Discomfort, Dizziness, Drug hypersensitivity, Drug ineffective, Drug intolerance, Dry mouth, Duodenal ulcer perforation, Dyspnoea, Facet joint syndrome, Fatigue, Fibromyalgia, Folliculitis, Gait inability, Gastrointestinal disorder, General physical health deterioration, Glossodynia, Hand deformity, Headache, Helicobacter infection, Hepatic cirrhosis, Hepatic enzyme increased, Hypersensitivity, Hypertension, Hypoaesthesia, Ill-defined disorder, Impaired healing, Infection, Inflammation, Infusion related reaction, Injury, Insomnia, Intentional product use issue, Irritable bowel syndrome, Joint dislocation, Joint range of motion decreased, Joint swelling, Lip dry, Liver disorder, Liver injury, Lower limb fracture, Lower respiratory tract infection, Lung disorder, Malaise, Maternal exposure during pregnancy, Maternal exposure timing unspecified, Mobility decreased, Muscle injury, Muscle spasms, Musculoskeletal pain, Musculoskeletal stiffness, Nasopharyngitis, Night sweats, Obesity, Oedema, Oedema peripheral, Osteoarthritis, Pain, Paraesthesia, Pemphigus, Pericarditis, Peripheral swelling, Peripheral venous disease, Prescribed overdose, Product use in unapproved indication, Product use issue, Pruritus, Psoriatic arthropathy, Pyrexia, Rash, Rheumatic fever, Rheumatoid arthritis, Rheumatoid factor positive, Road traffic accident, Sciatica, Sinusitis, Sleep disorder, Sleep disorder due to general medical condition, insomnia type, Stomatitis, Swelling, Swollen joint count increased, Synovitis, Systemic lupus erythematosus, Therapeutic product effect decreased, Therapy non-responder, Treatment failure, Type 2 diabetes mellitus, Urticaria, Vomiting, Weight increased, Wheezing, Wound, |
||||
TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, LORAZEPAM, CAFFEINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, LORAZEPAM, ERGOCALCIFEROL, TRIMETHOPRIM, |
||||
| 321 | 26495695 |
US |
75 | 2 |
Neuropathy peripheral, Alopecia, Dry skin, Skin exfoliation, Chapped lips, Fatigue, Diarrhoea, Cough, Arthritis, Apathy, |
||||
PALBOCICLIB, PALBOCICLIB, |
||||
| 322 | 26495985 |
US |
14 | |
Alopecia, Mucosal inflammation, |
||||
LOVOTIBEGLOGENE AUTOTEMCEL, |
||||
| 323 | 26496018 |
US |
72 | 2 |
Inappropriate schedule of product administration, Abdominal discomfort, Alopecia, |
||||
ABEMACICLIB, |
||||
| 324 | 26496019 |
US |
36 | 2 |
Heart rate increased, Retinal haemorrhage, Hepatic enzyme increased, White blood cell count decreased, Alopecia, Off label use, |
||||
TIRZEPATIDE, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE, DEXTROAMPHETAMINE SULFATE, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE SULFATE AND AMPHETAMINE ASPARTATE, |
||||
| 325 | 26496029 |
CA |
43 | 2 |
Abdominal discomfort, Abdominal pain, Abdominal pain upper, Alopecia, Anti-cyclic citrullinated peptide antibody positive, Arthralgia, Arthropathy, Asthenia, Blister, Blood cholesterol increased, Bursitis, C-reactive protein abnormal, Condition aggravated, Confusional state, Diarrhoea, Discomfort, Dizziness, Dry mouth, Duodenal ulcer perforation, Facet joint syndrome, Fatigue, Fibromyalgia, Folliculitis, General physical health deterioration, Glossodynia, Hand deformity, Helicobacter infection, Hepatic enzyme increased, Hypersensitivity, Impaired healing, Inflammation, Infusion related reaction, Injury, Irritable bowel syndrome, Joint range of motion decreased, Joint swelling, Lip dry, Liver injury, Lower respiratory tract infection, Lung disorder, Muscle injury, Muscle spasms, Musculoskeletal pain, Musculoskeletal stiffness, Nasopharyngitis, Nausea, Night sweats, Obesity, Oedema peripheral, Oedema, Osteoarthritis, Pain, Paraesthesia, Pemphigus, Pericarditis, Peripheral swelling, Peripheral venous disease, Psoriatic arthropathy, Pyrexia, Rash, Rheumatoid arthritis, Rheumatoid factor positive, Stomatitis, Swelling, Synovitis, Systemic lupus erythematosus, Urticaria, Vomiting, Weight increased, Wheezing, Wound, |
||||
SECUKINUMAB, OXYCODONE, RITUXIMAB, DICLOFENAC SODIUM, LEFLUNOMIDE, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, PREDNISONE, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, CALCIUM CARBONATE, ANTACID, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CERTOLIZUMAB PEGOL, CORTISONE ACETATE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, ETANERCEPT, ALENDRONATE SODIUM, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, ADALIMUMAB, INFLIXIMAB, ABATACEPT, ABATACEPT, NAPROXEN SODIUM, NAPROXEN SODIUM 220MG, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, PREDNISONE, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, TOFACITINIB, VITAMIN C, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, USTEKINUMAB, GOLIMUMAB, ACETAMINOPHEN AND CODEINE, LORAZEPAM, CAFFEINE, CAFFEINE CITRATE, DESOGESTREL AND ETHINYL ESTRADIOL, DEXPANTHENOL, ERGOCALCIFEROL, ASIAN GINSENG, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, LISINOPRIL, LORAZEPAM, LANSOPRAZOLE, PYRIDOXINE HYDROCHLORIDE, QUETIAPINE FUMARATE, QUETIAPINE, QUETIAPINE FUMARATE, QUETIAPINE, RAMIPRIL, THIAMINE HYDROCHLORIDE, SULFASALAZINE, VITAMIN A, LISINOPRIL, |
||||
| 326 | 26496048 |
US |
18 | |
Pain, Stomatitis, Alopecia, Skin hyperpigmentation, Ageusia, Hypersomnia, Gait disturbance, Pruritus, |
||||
LOVOTIBEGLOGENE AUTOTEMCEL, |
||||
| 327 | 26496055 |
US |
17 | |
Alopecia, Mouth haemorrhage, Chapped lips, Haematoma, Pain, Decreased appetite, |
||||
LOVOTIBEGLOGENE AUTOTEMCEL, |
||||
| 328 | 26496242 |
US |
29 | |
Alopecia, |
||||
LOVOTIBEGLOGENE AUTOTEMCEL, |
||||
| 329 | 26496466 |
EU |
35 | 2 |
Alopecia, |
||||
FLUCONAZOLE, MOMETASONE FUROATE, MOMETASONE, PEPPERMINT OIL, LEVONORGESTREL, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, |
||||
| 330 | 26496596 |
EU |
35 | 1 |
Erectile dysfunction, Genital hypoaesthesia, Alopecia, |
||||
TIRZEPATIDE, TIRZEPATIDE, |
||||
| 331 | 26500356 |
45 | 2 | |
Weight increased, Abdominal distension, Abdominal distension, Diarrhoea, Alopecia, |
||||
FREMANEZUMAB-VFRM, UBROGEPANT, RIZATRIPTAN BENZOATE, PRAZOSIN, ESCITALOPRAM, ALPRAZOLAM, |
||||
| 332 | 26486453 |
US |
43 | 2 |
Vitamin B12 decreased, Blood folate decreased, Alopecia, |
||||
TIRZEPATIDE, |
||||
| 333 | 26487224 |
US |
||
Pneumonia, Pseudomonas infection, Alopecia, |
||||
BRENSOCATIB, |
||||
| 334 | 26487399 |
JP |
78 | |
Triple negative breast cancer, Platelet count decreased, Neutrophil count decreased, White blood cell count decreased, Anaemia, Diarrhoea, Malaise, Alopecia, |
||||
SACITUZUMAB GOVITECAN, SACITUZUMAB GOVITECAN, SACITUZUMAB GOVITECAN, |
||||
| 335 | 26488141 |
US |
62 | 2 |
Alopecia, |
||||
TIRZEPATIDE, TIRZEPATIDE, ETANERCEPT, |
||||
| 336 | 26488430 |
EU |
2 | |
Polyneuropathy, Hypersensitivity, Decreased appetite, Constipation, Dizziness, Nasopharyngitis, Hot flush, Arthralgia, Libido decreased, Nausea, Rhinitis, Alopecia, Chills, |
||||
LETROZOLE, LETROZOLE TABLETS, LETROZOLE, LETROZOLE TABLETS, RIBOCICLIB, RIBOCICLIB, |
||||
| 337 | 26488982 |
US |
||
Alopecia, |
||||
TIRZEPATIDE, |
||||
| 338 | 26489479 |
US |
64 | 2 |
Alopecia, |
||||
TIRZEPATIDE, TIRZEPATIDE, FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE, |
||||
| 339 | 26489840 |
US |
||
Alopecia, |
||||
TIRZEPATIDE, |
||||
| 340 | 26490005 |
US |
||
Alopecia, |
||||
TIRZEPATIDE, |
||||
| 341 | 26490076 |
US |
2 | |
Alopecia, |
||||
TIRZEPATIDE, TIRZEPATIDE, |
||||
| 342 | 26490206 |
US |
||
Product residue present, Pruritus, Alopecia, |
||||
KETOCONAZOLE, |
||||
| 343 | 26490289 |
JP |
52 | |
Systemic lupus erythematosus, Alopecia, |
||||
VOCLOSPORIN, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, HYDROXYCHLOROQUINE SULFATE, LANSOPRAZOLE, DONEPEZIL HYDROCHLORIDE, LOSARTAN, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, DAPAGLIFLOZIN, |
||||
| 344 | 26490291 |
US |
64 | |
Nephrolithiasis, Kidney malrotation, Alopecia, Urinary tract infection, |
||||
DALFAMPRIDINE, MODAFINIL, ORAL SEMAGLUTIDE, ALLOPURINOL, FLUOXETINE HYDROCHLORIDE, GLIMEPIRIDE, PANTOPRAZOLE SODIUM, AMITRIPTYLINE HYDROCHLORIDE, AMITRIPTYLINE HYDROCHLORIDE, ZOLPIDEM TARTRATE, FAMOTIDINE, GABAPENTIN, MIRABEGRON, BETHANECHOL CHLORIDE, INSULIN GLARGINE, INSULIN ASPART, ERGOCALCIFEROL, OCRELIZUMAB, |
||||
| 345 | 26490639 |
US |
70 | 2 |
Alopecia, Drug ineffective, |
||||
CONJUGATED ESTROGENS, ESTROGENS, CONJUGATED, CONJUGATED ESTROGENS, ESTROGENS, CONJUGATED, |
||||
| 346 | 26490795 |
US |
||
Alopecia, |
||||
TIRZEPATIDE, |
||||
| 347 | 26490861 |
US |
64 | 2 |
Retinal disorder, Weight increased, Fatigue, Glaucoma, Sciatica, Osteosclerosis, Alopecia, Neurological infection, Intervertebral disc protrusion, |
||||
LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM, |
||||
| 348 | 26491067 |
US |
||
Alopecia, |
||||
TALQUETAMAB, |
||||
| 349 | 26491121 |
CA |
43 | 2 |
Systemic lupus erythematosus, Alopecia, Hypertension, Obesity, Swelling, Mobility decreased, Duodenal ulcer perforation, Nasopharyngitis, Musculoskeletal pain, Pericarditis, Pemphigus, Arthropathy, Inflammation, Lower respiratory tract infection, Wheezing, Fatigue, Hand deformity, Facet joint syndrome, Helicobacter infection, C-reactive protein increased, Lip dry, Confusional state, Asthenia, Urticaria, Psoriatic arthropathy, Stomatitis, Fibromyalgia, Nail disorder, Wound infection, Epilepsy, Hypoaesthesia, Live birth, Rheumatoid arthritis, Condition aggravated, Osteoarthritis, Type 2 diabetes mellitus, Muscle injury, Breast cancer stage III, Liver injury, Bursitis, Maternal exposure during pregnancy, |
||||
CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, |
||||
| 350 | 26491170 |
US |
2 | |
Alopecia, |
||||
KETOCONAZOLE, |
||||
| 351 | 26491283 |
US |
||
Alopecia, |
||||
TIRZEPATIDE, |
||||
| 352 | 26491376 |
US |
2 | |
Open fracture, Wrist fracture, Fall, Blood sodium decreased, Dry throat, Peripheral swelling, Somnolence, Fatigue, Alopecia, |
||||
OLAPARIB, FOLIC ACID, LOSARTAN POTASSIUM, LOSARTAN, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, AMLODIPINE BESYLATE, FISH OIL, ROSUVASTATIN CALCIUM, ERGOCALCIFEROL, IRON, GABAPENTIN, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, |
||||
| 353 | 26491435 |
US |
82 | 2 |
Alopecia, |
||||
TIRZEPATIDE, |
||||
| 354 | 26491650 |
EU |
41 | 2 |
Alopecia, |
||||
GALCANEZUMAB-GNLM, |
||||
| 355 | 26491853 |
EU |
45 | 2 |
Nephropathy toxic, Alopecia, Mucosal inflammation, Renal function test abnormal, Full blood count abnormal, Anaemia, |
||||
AMIVANTAMAB-VMJW, PEMETREXED, PEMETREXED DISODIUM, ZOLEDRONIC ACID, |
||||
| 356 | 26494555 |
31 | 2 | |
Anhidrosis, Autoimmune disorder, Loss of consciousness, Syncope, Alopecia, Injection site rash, |
||||
GALCANEZUMAB-GNLM, |
||||
| 357 | 26480641 |
US |
2 | |
Alopecia, |
||||
TOCILIZUMAB, TOCILIZUMAB, |
||||
| 358 | 26480805 |
US |
52 | 2 |
Alopecia, |
||||
TIRZEPATIDE, |
||||
| 359 | 26480862 |
US |
||
Alopecia, |
||||
TIRZEPATIDE, |
||||
| 360 | 26480896 |
US |
74 | 2 |
Idiopathic pulmonary fibrosis, Alopecia, Asthenia, Dizziness, Nausea, Headache, Decreased appetite, Weight decreased, Diarrhoea, Nausea, Headache, Vomiting, Abdominal pain upper, Abdominal pain upper, Fall, Memory impairment, Feeling abnormal, Haemorrhagic disorder, |
||||
NINTEDANIB, NINTEDANIB, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, |
||||
| 361 | 26481136 |
US |
80 | 2 |
Weight increased, Alopecia, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 362 | 26481285 |
US |
||
Alopecia, Hypophagia, |
||||
GLYCEROL PHENYLBUTYRATE, |
||||
| 363 | 26481451 |
BR |
76 | 1 |
Leukopenia, Thrombocytopenia, Tinnitus, Xeroderma, Pruritus, Alopecia, |
||||
ENFORTUMAB VEDOTIN, PEMBROLIZUMAB, |
||||
| 364 | 26481534 |
US |
47 | 1 |
Ear disorder, Alopecia, Off label use, |
||||
TEPROTUMUMAB, TEPROTUMUMAB, |
||||
| 365 | 26481772 |
EU |
43 | 2 |
Guillain-Barre syndrome, Alopecia, |
||||
DOLUTEGRAVIR SODIUM AND LAMIVUDINE, |
||||
| 366 | 26481991 |
US |
57 | 2 |
Dysgeusia, Alopecia, Fatigue, Drug resistance, |
||||
VISMODEGIB, CEFEPIME HYDROCHLORIDE, CEFEPIME, METRONIDAZOLE, METRONIDAZOLE TOPICAL, LEVOFLOXACIN, LEVOFLOXACIN IN 5% DEXTROSE, LEVOFLOXACIN, LEVOFLOXACIN IN 5% DEXTROSE, VANCOMYCIN HYDROCHLORIDE, VANCOMYCIN, |
||||
| 367 | 26482820 |
AU |
62 | 2 |
Visual impairment, Swollen tongue, Stomatitis, Tongue ulceration, Dysphagia, Dry mouth, Polydipsia, Arthralgia, Cough, Productive cough, Skin exfoliation, Injection site pain, Alopecia, Ear discomfort, Pain in extremity, Middle ear effusion, |
||||
INCLISIRAN, INCLISIRAN, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, |
||||
| 368 | 26483240 |
US |
71 | 2 |
Alopecia, |
||||
TIRZEPATIDE, |
||||
| 369 | 26483270 |
US |
||
Alopecia, |
||||
| 370 | 26483355 |
US |
||
Irritable bowel syndrome, Condition aggravated, Alopecia, Asthenia, |
||||
EVINACUMAB, EZETIMIBE, |
||||
| 371 | 26483662 |
US |
||
Alopecia, |
||||
TIRZEPATIDE, |
||||
| 372 | 26483743 |
US |
2 | |
Alopecia, Tanning, Skin discolouration, |
||||
GLATIRAMER ACETATE, DENOSUMAB, |
||||
| 373 | 26484629 |
JP |
2 | |
Leukopenia, Hypertension, Hypothyroidism, Diarrhoea, Nausea, Decreased appetite, Fatigue, Proteinuria, Vomiting, Weight decreased, Arthralgia, Palmar-plantar erythrodysaesthesia syndrome, Dysphonia, Asthenia, Stomatitis, Alanine aminotransferase increased, Aspartate aminotransferase increased, Anaemia, Headache, Myalgia, Rash, Mucosal inflammation, Platelet count decreased, Blood thyroid stimulating hormone increased, Hyperthyroidism, Constipation, Neutropenia, Alopecia, Neutrophil count decreased, White blood cell count decreased, |
||||
PEMBROLIZUMAB, LENVATINIB, |
||||
| 374 | 26485065 |
US |
70 | 2 |
Alopecia, |
||||
CYCLOSPORINE OPHTHALMIC SOLUTION, |
||||
| 375 | 26485633 |
62 | 2 | |
Alopecia, Nerve compression, |
||||
FULVESTRANT, RIBOCICLIB, |
||||
| 376 | 26485638 |
62 | 2 | |
Alopecia, Nerve compression, |
||||
RIBOCICLIB, |
||||
| 377 | 26476418 |
US |
2 | |
Alopecia, |
||||
ATENOLOL, |
||||
| 378 | 26476449 |
US |
2 | |
Anxiety, Alopecia, |
||||
ATENOLOL, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, AMLODIPINE, |
||||
| 379 | 26476629 |
CN |
||
Anaphylactic reaction, Clostridium difficile infection, Neoplasm, Hepatic function abnormal, Nervous system disorder, Pulmonary mass, Thyroid disorder, Nephropathy, Pyrexia, Erythema, Eye disorder, Mouth ulceration, Dyspepsia, Arthralgia, Anaemia, Herpes zoster, Rhinitis, Gingivitis, Gastrooesophageal reflux disease, Upper respiratory tract infection, Gastrointestinal infection, Urinary tract infection, Skin infection, Fungal infection, COVID-19, Chest discomfort, Haemoptysis, Tinnitus, Fatigue, Alopecia, Breast hyperplasia, Headache, Pharyngitis, Cough, Treatment noncompliance, Therapeutic response decreased, |
||||
INFLIXIMAB, AZATHIOPRINE, METHOTREXATE, METHOTREXATE SODIUM, THALIDOMIDE, |
||||
| 380 | 26476665 |
US |
||
Alopecia, |
||||
| 381 | 26476773 |
US |
||
Alopecia, |
||||
TIRZEPATIDE, |
||||
| 382 | 26476788 |
US |
||
Viral infection, Abdominal discomfort, Gastrooesophageal reflux disease, Fatigue, Alopecia, |
||||
ABEMACICLIB, |
||||
| 383 | 26477025 |
US |
43 | 2 |
Alopecia, Acne cystic, Haemorrhoids, Arthralgia, Scar, Abdominal pain, Fatigue, Pain, Diarrhoea, Drug ineffective, |
||||
UPADACITINIB, PROGESTERONE, PROGESTERONE, PROGESTERONE, |
||||
| 384 | 26477485 |
US |
89 | 1 |
Diarrhoea, Alopecia, Nasopharyngitis, Diarrhoea, Sinus congestion, |
||||
TAZEMETOSTAT, LOSARTAN POTASSIUM, LOSARTAN, SIMVASTATIN, ERGOCALCIFEROL, LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE HCL, LOPERAMIDE HYDROCHLORIDE ORAL, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, |
||||
| 385 | 26477746 |
US |
2 | |
Neuritis, Alopecia, Muscle spasms, Therapy cessation, |
||||
SONIDEGIB, |
||||
| 386 | 26478153 |
US |
54 | 2 |
Alopecia, |
||||
TIRZEPATIDE, TIRZEPATIDE, PROGESTERONE, ESTRADIOL, FOLLICULINUM, OOPHORINUM (SUIS), |
||||
| 387 | 26478161 |
EU |
27 | 1 |
Alopecia, Psoriasis, |
||||
INFLIXIMAB, AZATHIOPRINE, |
||||
| 388 | 26478725 |
US |
68 | 2 |
Alopecia, Drug ineffective, |
||||
TIRZEPATIDE, |
||||
| 389 | 26479323 |
US |
68 | 1 |
Fatigue, Alopecia, |
||||
RIPRETINIB, |
||||
| 390 | 26479367 |
US |
68 | 2 |
Nephrolithiasis, Neuropathy peripheral, Balance disorder, Herpes zoster, Pain in extremity, Arthralgia, Blood glucose increased, Pain, Haemoglobin increased, COVID-19, Headache, Alopecia, Malaise, Nausea, |
||||
TIRZEPATIDE, LEVOKETOCONAZOLE, LEVOKETOCONAZOLE, LEVOKETOCONAZOLE, LEVOKETOCONAZOLE, LEVOKETOCONAZOLE, PREGABALIN, |
||||
| 391 | 26479598 |
US |
52 | 2 |
Multiple sclerosis relapse, Wheezing, Injection site urticaria, Skin odour abnormal, Alopecia, Injection site pain, Hypersensitivity, Depression, Hyperhidrosis, Injection site mass, Drug ineffective, |
||||
GLATIRAMER ACETATE, GLATIRAMER ACETATE INJECTION, GLATIRAMER, AZELASTINE, OXYCODONE, BUPROPION, TIZANIDINE, MECLIZINE HCL 12.5 MG, MECLIZINE HCL 25 MG, MECLIZINE HYDROCHLORIDE, MECLIZINE, MECLIZINE HCL 25MG, MECLIZINE HCL 12.5MG, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, FOLIC ACID, MORPHINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, ERGOCALCIFEROL, ALBUTEROL SULFATE, ALBUTEROL, |
||||
| 392 | 26479917 |
US |
2 | |
Alopecia, Migraine, Ophthalmic migraine, |
||||
EVOLOCUMAB, |
||||
| 393 | 26471202 |
EU |
46 | 2 |
Rash macular, Foot operation, Cardiac failure, Renal colic, Rheumatic disorder, Alopecia, Acne, Skin laceration, Pain, |
||||
UPADACITINIB, UPADACITINIB, |
||||
| 394 | 26471312 |
US |
2 | |
Alopecia, |
||||
FEZOLINETANT, |
||||
| 395 | 26471388 |
US |
58 | 1 |
Blood glucose increased, Muscle spasticity, Gait disturbance, Feeding disorder, Drug intolerance, Mouth haemorrhage, Alopecia, Incorrect dose administered, |
||||
RIPRETINIB, RIPRETINIB, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, KETOCONAZOLE, KETOCONAZOLE FOAM, KETOCONAZOLE CREAM, 2%, TIRZEPATIDE, NYSTATIN, NYSTATIN OINTMENT, NYSTATIN CREAM, GLYBURIDE, |
||||
| 396 | 26471503 |
US |
2 | |
Sinus disorder, Illness, Alopecia, Dysphonia, |
||||
IMATINIB MESYLATE, ESOMEPRAZOLE MAGNESIUM, |
||||
| 397 | 26471555 |
CA |
43 | 2 |
Abdominal discomfort, Abdominal pain upper, Alopecia, Anti-cyclic citrullinated peptide antibody positive, Anxiety, Arthralgia, Arthropathy, Asthenia, Asthma, Autoimmune disorder, Blood cholesterol increased, C-reactive protein, C-reactive protein abnormal, Chest pain, Condition aggravated, Confusional state, Contraindicated product administered, Contusion, Decreased appetite, Deep vein thrombosis postoperative, Diarrhoea, Discomfort, Drug hypersensitivity, Dry mouth, Duodenal ulcer perforation, Dyspnoea, Fatigue, Fibromyalgia, Folliculitis, Gait inability, Gastrointestinal disorder, General physical health deterioration, Glossodynia, Hand deformity, Headache, Helicobacter infection, Hepatic enzyme increased, Hypersensitivity, Hypertension, Hypoaesthesia, Ill-defined disorder, Impaired healing, Infection, Irritable bowel syndrome, Joint swelling, Lip dry, Liver disorder, Maternal exposure during pregnancy, Pemphigus, Off label use, Therapeutic product effect decreased, |
||||
TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, RITUXIMAB, RITUXIMAB, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, |
||||
| 398 | 26471621 |
US |
||
Alopecia, |
||||
TIRZEPATIDE, |
||||
| 399 | 26471714 |
CN |
56 | 1 |
Pain in extremity, Peripheral swelling, Asthenia, Abdominal discomfort, Alopecia, |
||||
PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), CISPLATIN, CISPLATIN, CISPLATIN, CISPLATIN, CISPLATIN, CISPLATIN, CISPLATIN, CISPLATIN, |
||||
| 400 | 26471773 |
US |
73 | 2 |
Alopecia, |
||||
TIRZEPATIDE, TIRZEPATIDE, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-04-28